405 related articles for article (PubMed ID: 2069229)
1. Thalassemias in Sardinia: molecular pathology, phenotype-genotype correlation, and prevention.
Cao A; Rosatelli C; Pirastu M; Galanello R
Am J Pediatr Hematol Oncol; 1991; 13(2):179-88. PubMed ID: 2069229
[TBL] [Abstract][Full Text] [Related]
2. [Current views of thalassemia intermedia].
Longinotti M; Dore F; Oggiano L; Pardini S; Pistidda P; Guiso L; Frogheri L; Bonfigli S; Murineddu M; Rimini E
Recenti Prog Med; 1992 Apr; 83(4):233-40. PubMed ID: 1626119
[TBL] [Abstract][Full Text] [Related]
3. [Molecular-genetic characteristics of alpha, beta and delta beta-thalassemias in 139 heterozygotes in 56 unrelated Czech and Slovak families (Priority description of 3 beta-thalassemia mutations, an extensive alpha-thalassemia 2 (18+ kb) deletion and a Swiss-type nondeletion hereditary persistence of hemoglobin F)].
Indrák K; Divoký V; Brabec V; Indráková J; Svobodová M; Huisman TH
Vnitr Lek; 1993 Oct; 39(10):969-78. PubMed ID: 7694425
[TBL] [Abstract][Full Text] [Related]
4. The prevention of thalassemia in Sardinia.
Cao A; Rosatelli C; Galanello R; Monni G; Olla G; Cossu P; Ristaldi MS
Clin Genet; 1989 Nov; 36(5):277-85. PubMed ID: 2598483
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology and detection of beta-thalassemias.
Cao A; Murru S
Prog Clin Biol Res; 1989; 309():3-11. PubMed ID: 2675099
[TBL] [Abstract][Full Text] [Related]
6. The molecular pathology of beta-thalassemia in Turkey: the Boğaziçi university experience.
Basak AN
Hemoglobin; 2007; 31(2):233-41. PubMed ID: 17486506
[TBL] [Abstract][Full Text] [Related]
7. Silent thalassemias: genotypes and phenotypes.
Bianco I; Cappabianca MP; Foglietta E; Lerone M; Deidda G; Morlupi L; Grisanti P; Ponzini D; Rinaldi S; Graziani B
Haematologica; 1997; 82(3):269-80. PubMed ID: 9234571
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of beta-thalassemia in South Vietnam.
Svasti S; Hieu TM; Munkongdee T; Winichagoon P; Van Be T; Van Binh T; Fucharoen S
Am J Hematol; 2002 Oct; 71(2):85-8. PubMed ID: 12353305
[TBL] [Abstract][Full Text] [Related]
9. [A rare thalassemia intermedia case caused by co-existence of Hb H disease (--(SEA)/-alpha(4.2)) and beta-thalassemia major (beta (CD17A)>T/beta (IVS2-654C)>T): implications for prenatal diagnosis].
Li Q; Li LY; Mo QH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):16-9. PubMed ID: 18227017
[TBL] [Abstract][Full Text] [Related]
10. Interaction between deletion delta-thalassemia and beta zero-thalassemia (codon 39 nonsense mutation) in a Sardinian family.
Galanello R; Podda A; Melis MA; Monne M; Cao A
Prog Clin Biol Res; 1989; 316B():113-21. PubMed ID: 2482492
[TBL] [Abstract][Full Text] [Related]
11. [Molecular genetics of the thalassemias in Argentina].
Varela V; Rossetti LC; Binaghi A; Targovnik HM; Abreu MS
Sangre (Barc); 1999 Jun; 44(3):210-5. PubMed ID: 10481583
[TBL] [Abstract][Full Text] [Related]
12. Identification of deletion and triple alpha-globin gene haplotypes in the Montreal beta-thalassemia screening program: implications for genetic medicine.
Akerman BR; Fujiwara TM; Lancaster GA; Morgan K; Scriver CR
Am J Med Genet; 1990 May; 36(1):76-84. PubMed ID: 2333910
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of thalassemia in southeast Asia.
Winichagoon P; Fucharoen S; Wilairat P; Fukumaki Y
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():235-40. PubMed ID: 8629113
[TBL] [Abstract][Full Text] [Related]
14. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
15. Co-inheritance of Hb Pak Num Po, a novel alpha1 gene mutation, and alpha0 thalassemia associated with transfusion-dependent Hb H disease.
Viprakasit V; Tanphaichitr VS; Veerakul G; Chinchang W; Petrarat S; Pung-Amritt P; Higgs DR
Am J Hematol; 2004 Mar; 75(3):157-63. PubMed ID: 14978697
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong -- implications for population screening.
Lau YL; Chan LC; Chan YY; Ha SY; Yeung CY; Waye JS; Chui DH
N Engl J Med; 1997 May; 336(18):1298-301. PubMed ID: 9113933
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of beta-thalassemia minor in Taiwan.
Chang JG; Lin CP; Liu TC; Chiou SS; Chen PH; Lee LS; Chen TP
Int J Hematol; 1994 Jun; 59(4):267-72. PubMed ID: 8086620
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of beta zero-thalassemia intermedia in Sardinia.
Galanello R; Dessi E; Melis MA; Addis M; Sanna MA; Rosatelli C; Argiolu F; Giagu N; Turco MP; Cacace E
Blood; 1989 Aug; 74(2):823-7. PubMed ID: 2473806
[TBL] [Abstract][Full Text] [Related]
20. [Molecular diagnosis of beta-thalassemia intermedia].
Chen J; Liu W; Chen M
Zhonghua Yi Xue Za Zhi; 1997 Aug; 77(8):575-8. PubMed ID: 9772460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
